Skip to content

Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults

Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults: Evidence From NHANES: 2003-2020

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07291726
Enrollment
0
Registered
2025-12-18
Start date
2024-04-01
Completion date
2024-08-06
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Health, Overweight/Obesity

Brief summary

This cross-sectional study draws on data from the National Health and Nutrition Examination Survey (NHANES) database. The primary objective is to investigate the associations between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the related metabolic abnormalities, among the U.S. general population. By analyzing this large-scale, nationally representative dataset, the investigators seek to generate evidence that can inform public health policies and clinical practice-ultimately contributing to a deeper understanding of population-level health challenges and the development of targeted strategies to address them.

Interventions

This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.

Sponsors

University-Town Hospital of Chongqing Medical University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Participants with complete data on composite dietary antioxidant index from the NHANES database * Participants with complete body mass index (BMI) data from the NHANES database * Individuals aged 18 years and older

Exclusion criteria

* Participants with missing key data (composite dietary antioxidant index or BMI) * Individuals who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Overweight/Obesity Assessed by Body Mass Index (BMI)Baseline: Data collection for calculating BMI occurs during the specific NHANES survey cycle relevant to this study (single - time - point cross - sectional assessment).Body Mass Index (BMI) will be calculated as weight (in kilograms) divided by the square of height (in meters). According to the World Health Organization's classification, a BMI of 25.0 - 29.9 kg/m² is considered overweight, and a BMI of 30.0 kg/m² or higher is considered obese. Data on weight and height will be obtained from the NHANES dataset.
Metabolic Phenotype Classification (Metabolically Healthy vs. Unhealthy) Assessed by NCEP ATP III Metabolic Syndrome ComponentsBaseline: Data on metabolic components for phenotype classification will be collected during the corresponding NHANES survey cycle for this study, reflecting a single-time-point cross-sectional assessment.Metabolic phenotypes are classified as metabolically healthy or unhealthy based on the components of metabolic syndrome defined in the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Waist circumference data is not used in this classification due to its high correlation with BMI. A participant is defined as metabolically healthy if they have none or only one of the following four metabolic abnormalities: (1) Serum triglycerides (TG) ≥ 150 mg/dL; (2) Serum high-density lipoprotein cholesterol (HDL-C) \< 40 mg/dL in men or \< 50 mg/dL in women; (3) Fasting glucose ≥ 100 mg/dL or use of hypoglycemic drugs; (4) Blood pressure ≥ 130/85 mmHg or use of antihypertensive drugs. A participant is defined as metabolically unhealthy if they have two or more of the above metabolic abnormalities. Relevant data will be retrieved from the NHANES database.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026